Vol. 19 No. 4(73) (2020), Artykuły
Vol. 19 No. 4(73) (2020)

CMV seropositivity does not increase the risk of death among elderly nursing home residents

Artykuły
Published 2020-12-08
Dorota Pytka
Department of Clinical Nursing, Medical University of Warsaw, Poland
Bożena Czarkowska-Pączek
Department of Clinical Nursing, Medical University of Warsaw, Poland
https://orcid.org/0000-0002-1023-3057
Aleksandra Wyczałkowska-Tomasik
Department of Immunology, Transplantology, and Internal Diseases, Medical University of Warsaw, Poland

Abstract

CMV SEROPOSITIVITY DOES NOT INCREASE THE RISK OF DEATH AMONG ELDERLY NURSING HOME RESIDENTS

Aim. The aim of this study was to assess the anti-CMV antibody titre, the presence of genetic material of the virus in the plasma ofelderly residents of nursing homes and the impact of the CMV infection on the risk of death.

Material and methods. The number of 202 residents of a nursing home in Warsaw, aged 65 and over, were observed for 1095 days (3 years) between 2015 and 2018. During this period 126 (62.4%) residents died. Plasma CMV DNA levels were assessed using real-time PCR. Anti-CMV antibody titre was measured with the use of commercially available ARCHITECT CMV test.

Results. No genetic material of the CMV was found in the studied group of the residents. The mean IgG titre did not diff er between those who survived and those who deceased (p=1). Pearson’s Chi-squared test and Fisher’s exact test did not reveal any differences in the rate of deaths among the groups of seronegative, seropositive < 250 IgG [Au/ml], and seropositive > 250 IgG [Au/ml] residents. Kaplan-Meyers survival curves confirmed these results.

Conclusions. We did not demonstrate that CMV infection or the anti-CMV antibody titer have any effect on the risk of death in the study group.

CMV seropositivity does not increase the risk of death among elderly nursing home residents.pdf

References

1. Lubeck PR, Doerr HW, Rabenau HF. Epidemiology of human cytomegalovirus (HCMV) in an urban region of Germany: what has changed? Med Microbiol Immunol. 2010;199:53-60.

2. Matheï C, Adriaensen W, Vaes B, et al. No relation between CMV infection and mortality in the oldest old: results from the Belfrail study. Age Ageing. 2015;44(1):130-135. doi: 10.1093/ageing/afu094.

3. Michael J. Cannon, D. Schmid S, et al. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Reviews in Medical Virology. 2010;20 (4):202-213.

4. Feinstein L, Douglas CE, Stebbins RC, et al. Does cytomegalovirus infection contribute to socioeconomic disparities in all-cause mortality? Mech Ageing Dev. 2016;158:53-61. doi:10.1016/j.mad.2016.06.001

5. Stowe RP, Kozlova EV, Yetman DL, et al. Chronic herpesvirus reactivation occurs in aging. Exp Gerontol. 2007;42:563-570.

6. Aiello AE, Haan MN, Blythe L, et al. The influence of latent viral infection on rate of cognitive decline over 4 years. J Am Geriatr Soc. 2006;54:1046-1054. doi: 10.1111/j.1532-5415.2006.00796.x.

7. Schmaltz HN, Fried LP, Xue QL, et al. Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J Am Geriatr Soc. 2005;53(5):747-754.

8. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146-M156.

9. Simanek AM, Dowd JB, Aiello AE. Persistent pathogens linking socioeconomic position and cardiovascular disease in the US. Int J Epidemiol. 2009;38(3):775–787.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.

Copyright (c) 2020 Authors